A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast Cancer
Clinical trial NCT04214288 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04214288
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-22
- Primary completion
- 2022-08-30
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.